Protective effects of deep sea water against doxorubicin‑induced cardiotoxicity in H9c2 cardiac muscle cells

Lee,Do‑Hyung; Kim,Soyoung; Nam,Kyung‑Soo

doi:10.3892/ijo.2014.2666

Protective effects of deep sea water against doxorubicin‑induced cardiotoxicity in H9c2 cardiac muscle cells

Authors:
- Do‑Hyung Lee
- Soyoung Kim
- Kyung‑Soo Nam
View Affiliations

Affiliations: Department of Pharmacology, College of Medicine and Intractable Disease Research Center, Dongguk University, Gyeongju, Gyeongsangbuk-do 780‑714, Republic of Korea
Published online on: September 22, 2014 https://doi.org/10.3892/ijo.2014.2666
Pages: 2569-2575

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Doxorubicin (DOX) is one of the most effective chemotherapeutic agents in the treatment of a variety of tumors. However, its clinical use has been compromised by the risk of cardiotoxicity. Thus, many efforts have been focused on exploring new strategies to prevent or reverse DOX‑induced cardiotoxicity. Recently, deep sea water (DSW) has drawn much scientific interest for therapeutic intervention due to its enrichment in nutrients and minerals. In this study, we investigated whether DSW has protective effects against DOX‑induced cardiotoxicity. Pre‑treatment with DSW significantly increased the viability of DOX‑treated rat H9c2 cardiac muscle cells. This protective effect of DSW appears to be mediated through the inhibition of DNA damage rather than suppression of reactive oxygen species (ROS) production in DOX‑treated H9c2 cardiac muscle cells. The inhibitory effect of DSW on DOX‑induced DNA damage subsequently attenuated apoptotic signaling such as activation of cysteine‑aspartic acid protease‑3 (caspase‑3) and fragmentation of poly(ADP‑ribose) polymerase (PARP), whereas the expression of anti‑apoptotic protein B‑cell lymphoma‑extra large (Bcl‑xL) was increased. Moreover, DSW treatment rescued the activation of protein kinase B (Akt) to protect cells from DOX‑triggered apoptosis. Taken together, our data showed that DSW has protective effects against DOX‑induced cardiotoxicity, suggesting that DSW has some promise as a novel protective supplement for promoting the successful use of DOX in clinical regimen.

View Figures

View References

1	Minotti G, Menna P, Salvatorelli E, Cairo G and Gianni L: Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 56:185–229. 2004. View Article : Google Scholar : PubMed/NCBI
2	Tan C, Tasaka H, Yu KP, Murphy ML and Karnofsky DA: Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer. 20:333–353. 1967. View Article : Google Scholar : PubMed/NCBI
3	Gharib MI and Burnett AK: Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. Eur J Heart Fail. 4:235–242. 2002. View Article : Google Scholar : PubMed/NCBI
4	Singal PK, Li T, Kumar D, Danelisen I and Iliskovic N: Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem. 207:77–86. 2000. View Article : Google Scholar : PubMed/NCBI
5	Von Hoff DD, Layard MW, Basa P, et al: Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 91:710–717. 1979.PubMed/NCBI
6	Rajagopalan S, Politi PM, Sinha BK and Myers CE: Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res. 48:4766–4769. 1988.PubMed/NCBI
7	Simůnek T, Stérba M, Popelová O, Adamcová M, Hrdina R and Gersl V: Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep. 61:154–171. 2009.PubMed/NCBI
8	Vásquez-Vivar J, Martasek P, Hogg N, Masters BS, Pritchard KA Jr and Kalyanaraman B: Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry. 36:11293–11297. 1997.PubMed/NCBI
9	Goto S, Ihara Y, Urata Y, et al: Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi. FASEB J. 15:2702–2714. 2001. View Article : Google Scholar : PubMed/NCBI
10	L’Ecuyer T, Sanjeev S, Thomas R, et al: DNA damage is an early event in doxorubicin-induced cardiac myocyte death. Am J Physiol Heart Circ Physiol. 291:H1273–H1280. 2006.PubMed/NCBI
11	Liu J, Mao W, Ding B and Liang CS: ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am J Physiol Heart Circ Physiol. 295:H1956–H1965. 2008. View Article : Google Scholar : PubMed/NCBI
12	Chularojmontri L, Gerdprasert O and Wattanapitayakul SK: Pummelo protects doxorubicin-induced cardiac cell death by reducing oxidative stress, modifying glutathione transferase expression, and preventing cellular senescence. Evid Based Complement Alternat Med. 2013:2548352013.
13	Das J, Ghosh J, Manna P and Sil PC: Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochem Pharmacol. 81:891–909. 2011. View Article : Google Scholar : PubMed/NCBI
14	Ghosh J, Das J, Manna P and Sil PC: The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis. Biomaterials. 32:4857–4866. 2011. View Article : Google Scholar : PubMed/NCBI
15	Doroshow JH, Locker GY, Ifrim I and Myers CE: Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest. 68:1053–1064. 1981. View Article : Google Scholar : PubMed/NCBI
16	Shimpo K, Nagatsu T, Yamada K, et al: Ascorbic acid and adriamycin toxicity. Am J Clin Nutr. 54(Suppl 6): 1298S–1301S. 1991.PubMed/NCBI
17	Swain SM and Vici P: The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review. J Cancer Res Clin Oncol. 130:1–7. 2004. View Article : Google Scholar : PubMed/NCBI
18	Huelsenbeck J, Henninger C, Schad A, Lackner KJ, Kaina B and Fritz G: Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity. Cell Death Dis. 2:e1902011. View Article : Google Scholar : PubMed/NCBI
19	Siveski-Iliskovic N, Hill M, Chow DA and Singal PK: Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation. 91:10–15. 1995. View Article : Google Scholar : PubMed/NCBI
20	Siveski-Iliskovic N, Kaul N and Singal PK: Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation. 89:2829–2835. 1994. View Article : Google Scholar : PubMed/NCBI
21	Nakasone T and Akeda S: The application of deep sea water in Japan. UJNR Technical Report. 28:69–75. 1999.
22	Hwang HS, Kim SH, Yoo YG, et al: Inhibitory effect of deep-sea water on differentiation of 3T3-L1 adipocytes. Mar Biotechnol (NY). 11:161–168. 2009. View Article : Google Scholar : PubMed/NCBI
23	Radhakrishnan G, Yamamoto M, Maeda H, et al: Intake of dissolved organic matter from deep sea water inhibits atherosclerosis progression. Biochem Biophys Res Commun. 387:25–30. 2009. View Article : Google Scholar : PubMed/NCBI
24	Kim S, Chun SY, Lee DH, Lee KS and Nam KS: Mineral-enriched deep-sea water inhibits the metastatic potential of human breast cancer cell lines. Int J Oncol. 43:1691–1700. 2013.PubMed/NCBI
25	Lee KS, Shin JS, Kwon YS, Moon DS and Nam KS: Suppression of cancer progression and metastasis in HT-29 human colorectal adenocarcinoma by deep sea water. Biotechnol Bioproc Eng. 18:194–200. 2013. View Article : Google Scholar
26	Hartwig A: Role of magnesium in genomic stability. Mutat Res. 475:113–121. 2001. View Article : Google Scholar : PubMed/NCBI
27	Tejero-Taldo MI, Chmielinska JJ and Weglicki WB: Chronic dietary Mg²⁺ deficiency induces cardiac apoptosis in the rat heart. Magnes Res. 20:208–212. 2007.
28	van Asperen J, van Tellingen O, Tijssen F, Schinkel AH and Beijnen JH: Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein. Br J Cancer. 79:108–113. 1999.PubMed/NCBI
29	Olive PL: Detection of DNA damage in individual cells by analysis of histone H2AX phosphorylation. Methods Cell Biol. 75:355–373. 2004. View Article : Google Scholar : PubMed/NCBI
30	Brantley-Finley C, Lyle CS, Du L, et al: The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem Pharmacol. 66:459–469. 2003. View Article : Google Scholar : PubMed/NCBI
31	Negoro S, Oh H, Tone E, et al: Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation. 103:555–561. 2001. View Article : Google Scholar : PubMed/NCBI
32	Ahmed NN, Grimes HL, Bellacosa A, Chan TO and Tsichlis PN: Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA. 94:3627–3632. 1997. View Article : Google Scholar : PubMed/NCBI
33	Wang Y: Mitogen-activated protein kinases in heart development and diseases. Circulation. 116:1413–1423. 2007. View Article : Google Scholar : PubMed/NCBI
34	Saris NE, Mervaala E, Karppanen H, Khawaja JA and Lewenstam A: Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 294:1–26. 2000.PubMed/NCBI
35	Song Y, Manson JE, Cook NR, Albert CM, Buring JE and Liu S: Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol. 96:1135–1141. 2005. View Article : Google Scholar : PubMed/NCBI
36	Almoznino-Sarafian D, Sarafian G, Berman S, et al: Magnesium administration may improve heart rate variability in patients with heart failure. Nutr Metab Cardiovasc Dis. 19:641–645. 2009. View Article : Google Scholar : PubMed/NCBI
37	Kluck RM, McDougall CA, Harmon BV and Halliday JW: Calcium chelators induce apoptosis - evidence that raised intracellular ionised calcium is not essential for apoptosis. Biochim Biophys Acta. 1223:247–254. 1994. View Article : Google Scholar : PubMed/NCBI
38	Turner CP, Connell J, Blackstone K and Ringler SL: Loss of calcium and increased apoptosis within the same neuron. Brain Res. 1128:50–60. 2007. View Article : Google Scholar : PubMed/NCBI
39	Feng H, Guo L, Gao H and Li XA: Deficiency of calcium and magnesium induces apoptosis via scavenger receptor BI. Life Sci. 88:606–612. 2011. View Article : Google Scholar : PubMed/NCBI
40	Yang CY, Chiu HF, Cheng MF, Hsu TY and Wu TN: Calcium and magnesium in drinking water and the risk of death from breast cancer. J Toxicol Environ Health A. 60:231–241. 2000. View Article : Google Scholar : PubMed/NCBI